P54753 (EPHB3_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 136.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Ephrin type-B receptor 3 EC=2.7.10.1 Alternative name(s): EPH-like tyrosine kinase 2 Short name=EPH-like kinase 2 Embryonic kinase 2 Short name=EK2 Short name=hEK2 Tyrosine-protein kinase TYRO6 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 998 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Receptor tyrosine kinase which binds promiscuously transmembrane ephrin-B family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Generally has an overlapping and redundant function with EPHB2. Like EPHB2, functions in axon guidance during development regulating for instance the neurons forming the corpus callosum and the anterior commissure, 2 major interhemispheric connections between the temporal lobes of the cerebral cortex. Beside its role in axon guidance plays also an important redundant role with other ephrin-B receptors in development and maturation of dendritic spines and the formation of excitatory synapses. Controls other aspects of development through regulation of cell migration and positioning. This includes angiogenesis, palate development and thymic epithelium development for instance. Forward and reverse signaling through the EFNB2/EPHB3 complex also regulate migration and adhesion of cells that tubularize the urethra and septate the cloaca. Finally, plays an important role in intestinal epithelium differentiation segregating progenitor from differentiated cells in the crypt. Ref.5 |
| Catalytic activity | ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate. |
| Subunit structure | Heterotetramer upon binding of the ligand. The heterotetramer is composed of an ephrin dimer and a receptor dimer. Oligomerization is probably required to induce biological responses By similarity. |
| Subcellular location | Cell membrane; Single-pass type I membrane protein. Cell projection › dendrite By similarity Ref.5. |
| Tissue specificity | Ubiquitous. |
| Post-translational modification | Phosphorylated. Autophosphorylates upon ligand-binding. Autophosphorylation on Tyr-614 is required for interaction with SH2 domain-containing proteins. Ref.1 Ref.4 Ref.5 |
| Sequence similarities | Belongs to the protein kinase superfamily. Tyr protein kinase family. Ephrin receptor subfamily. Contains 1 Eph LBD (Eph ligand-binding) domain. Contains 2 fibronectin type-III domains. Contains 1 protein kinase domain. Contains 1 SAM (sterile alpha motif) domain. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 33 | 33 | Potential | |||||||||||||||||||||||||||||||||
| Chain | 34 – 998 | 965 | Ephrin type-B receptor 3 | PRO_0000016831 | ||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||
| Topological domain | 34 – 559 | 526 | Extracellular Potential | |||||||||||||||||||||||||||||||||
| Transmembrane | 560 – 580 | 21 | Helical; Potential | |||||||||||||||||||||||||||||||||
| Topological domain | 581 – 998 | 418 | Cytoplasmic Potential | |||||||||||||||||||||||||||||||||
| Domain | 39 – 217 | 179 | Eph LBD | |||||||||||||||||||||||||||||||||
| Domain | 340 – 443 | 104 | Fibronectin type-III 1 | |||||||||||||||||||||||||||||||||
| Domain | 453 – 544 | 92 | Fibronectin type-III 2 | |||||||||||||||||||||||||||||||||
| Domain | 633 – 896 | 264 | Protein kinase | |||||||||||||||||||||||||||||||||
| Domain | 925 – 989 | 65 | SAM | |||||||||||||||||||||||||||||||||
| Nucleotide binding | 639 – 647 | 9 | ATP By similarity | |||||||||||||||||||||||||||||||||
| Motif | 996 – 998 | 3 | PDZ-binding Potential | |||||||||||||||||||||||||||||||||
| Compositional bias | 199 – 336 | 138 | Cys-rich | |||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||
| Active site | 758 | 1 | Proton acceptor By similarity | |||||||||||||||||||||||||||||||||
| Binding site | 665 | 1 | ATP By similarity | |||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||
| Modified residue | 614 | 1 | Phosphotyrosine; by autocatalysis | |||||||||||||||||||||||||||||||||
| Glycosylation | 351 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||
| Glycosylation | 445 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||
| Disulfide bond | 81 ↔ 199 | Ref.7 | ||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||
| Natural variant | 168 | 1 | R → L in a lung small cell carcinoma sample; somatic mutation. Ref.8 | VAR_042176 | ||||||||||||||||||||||||||||||||
| Natural variant | 440 | 1 | R → C. Ref.8 Corresponds to variant rs56029711 [ dbSNP | Ensembl ]. | VAR_042177 | ||||||||||||||||||||||||||||||||
| Natural variant | 579 | 1 | I → V. Ref.8 Corresponds to variant rs56103851 [ dbSNP | Ensembl ]. | VAR_042178 | ||||||||||||||||||||||||||||||||
| Natural variant | 601 | 1 | I → L. Ref.8 Corresponds to variant rs56129875 [ dbSNP | Ensembl ]. | VAR_042179 | ||||||||||||||||||||||||||||||||
| Natural variant | 724 | 1 | R → W in a lung neuroendocrine carcinoma sample; somatic mutation. Ref.8 | VAR_042180 | ||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||
| Mutagenesis | 614 | 1 | Y → F: Partial loss of phosphorylation and loss of interaction with SH2-containing proteins. Ref.4 | |||||||||||||||||||||||||||||||||
| Mutagenesis | 665 | 1 | K → R: Kinase-dead. Loss of autophosphorylation. Ref.4 | |||||||||||||||||||||||||||||||||
| Sequence conflict | 367 | 1 | G → V in CAA53021. Ref.1 | |||||||||||||||||||||||||||||||||
| Sequence conflict | 406 – 408 | 3 | TER → SEP in CAA53021. Ref.1 | |||||||||||||||||||||||||||||||||
| Sequence conflict | 412 | 1 | I → T in CAA53021. Ref.1 | |||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||
| Beta strand | 39 – 44 | 6 | ||||||||||||||||||||||||||||||||||
| Helix | 45 – 47 | 3 | ||||||||||||||||||||||||||||||||||
| Beta strand | 55 – 58 | 4 | ||||||||||||||||||||||||||||||||||
| Beta strand | 63 – 68 | 6 | ||||||||||||||||||||||||||||||||||
| Beta strand | 74 – 80 | 7 | ||||||||||||||||||||||||||||||||||
| Beta strand | 85 – 87 | 3 | ||||||||||||||||||||||||||||||||||
| Beta strand | 90 – 93 | 4 | ||||||||||||||||||||||||||||||||||
| Beta strand | 103 – 114 | 12 | ||||||||||||||||||||||||||||||||||
| Helix | 116 – 118 | 3 | ||||||||||||||||||||||||||||||||||
| Beta strand | 130 – 139 | 10 | ||||||||||||||||||||||||||||||||||
| Beta strand | 155 – 160 | 6 | ||||||||||||||||||||||||||||||||||
| Beta strand | 175 – 181 | 7 | ||||||||||||||||||||||||||||||||||
| Beta strand | 186 – 198 | 13 | ||||||||||||||||||||||||||||||||||
| Beta strand | 200 – 210 | 11 | ||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "PCR mediated detection of a new human receptor-tyrosine-kinase, HEK 2." Boehme B., Holtrich U., Wolf G., Luzius H., Grzeschik K.-H., Strebhardt K., Ruebsamen-Waigmann H. Oncogene 8:2857-2862(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], IDENTIFICATION OF EFNB1 AND EFNB2 AS LIGANDS, AUTOPHOSPHORYLATION. Tissue: Embryo. |
| [2] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Uterus. |
| [3] | "Unified nomenclature for Eph family receptors and their ligands, the ephrins." Eph nomenclature committee Cell 90:403-404(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NOMENCLATURE. |
| [4] | "Tyrosine-614, the major autophosphorylation site of the receptor tyrosine kinase HEK2, functions as multi-docking site for SH2-domain mediated interactions." Hock B., Boehme B., Karn T., Feller S., Ruebsamen-Waigmann H., Strebhardt K. Oncogene 17:255-260(1998) [PubMed] [Europe PMC] [Abstract] Cited for: AUTOPHOSPHORYLATION, MUTAGENESIS OF TYR-614 AND LYS-665. |
| [5] | "Inhibition of integrin-mediated cell adhesion but not directional cell migration requires catalytic activity of EphB3 receptor tyrosine kinase. Role of Rho family small GTPases." Miao H., Strebhardt K., Pasquale E.B., Shen T.L., Guan J.L., Wang B. J. Biol. Chem. 280:923-932(2005) [PubMed] [Europe PMC] [Abstract] Cited for: AUTOPHOSPHORYLATION, FUNCTION IN CELL ADHESION, FUNCTION IN CELL MIGRATION, SUBCELLULAR LOCATION. |
| [6] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [7] | "Ligand binding domain of human EPHB3." Structural genomics consortium (SGC) Submitted (JAN-2011) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 39-211, DISULFIDE BOND. |
| [8] | "Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. Stratton M.R.Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] LEU-168; CYS-440; VAL-579; LEU-601 AND TRP-724. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X75208 mRNA. Translation: CAA53021.1. BC052968 mRNA. Translation: AAH52968.1. | ||||||||||||
| IPI | IPI00289329. | ||||||||||||
| PIR | S37627. | ||||||||||||
| RefSeq | NP_004434.2. NM_004443.3. | ||||||||||||
| UniGene | Hs.2913. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P54753. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | P54753. 2 interactions. | ||||||||||||
| STRING | 9606.ENSP00000332118. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P54753. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 76803655. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | P54753. | ||||||||||||
| PRIDE | P54753. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 2049. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000330394; ENSP00000332118; ENSG00000182580. | ||||||||||||
| GeneID | 2049. | ||||||||||||
| KEGG | hsa:2049. | ||||||||||||
| UCSC | uc003foz.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 2049. | ||||||||||||
| GeneCards | GC03P184279. | ||||||||||||
| HGNC | HGNC:3394. EPHB3. | ||||||||||||
| HPA | HPA007698. HPA008184. | ||||||||||||
| MIM | 601839. gene. | ||||||||||||
| neXtProt | NX_P54753. | ||||||||||||
| PharmGKB | PA27826. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG0515. | ||||||||||||
| HOGENOM | HOG000233856. | ||||||||||||
| HOVERGEN | HBG062180. | ||||||||||||
| InParanoid | P54753. | ||||||||||||
| KO | K05112. | ||||||||||||
| OMA | LQQYITP. | ||||||||||||
| OrthoDB | EOG4W9J35. | ||||||||||||
| PhylomeDB | P54753. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| BRENDA | 2.7.10.1. 2681. | ||||||||||||
| Pathway_Interaction_DB | ephbfwdpathway. EPHB forward signaling. ephrinb_ephbpathway. EphrinB-EPHB pathway. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P54753. | ||||||||||||
| Bgee | P54753. | ||||||||||||
| CleanEx | HS_EPHB3. | ||||||||||||
| Genevestigator | P54753. | ||||||||||||
| GermOnline | ENSG00000182580. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 1.10.150.50. 1 hit. 2.60.40.10. 2 hits. | ||||||||||||
| InterPro | IPR001090. Ephrin_rcpt_lig-bd_dom. IPR003961. Fibronectin_type3. IPR008979. Galactose-bd-like. IPR013783. Ig-like_fold. IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR001660. SAM. IPR013761. SAM/pointed. IPR021129. SAM_type1. IPR001245. Ser-Thr/Tyr_kinase_cat_dom. IPR011641. Tyr-kin_ephrin_A/B_rcpt-like. IPR008266. Tyr_kinase_AS. IPR020635. Tyr_kinase_cat_dom. IPR016257. Tyr_kinase_ephrin_rcpt. IPR001426. Tyr_kinase_rcpt_V_CS. [Graphical view] | ||||||||||||
| Pfam | PF01404. Ephrin_lbd. 1 hit. PF00041. fn3. 2 hits. PF07699. GCC2_GCC3. 1 hit. PF07714. Pkinase_Tyr. 1 hit. PF00536. SAM_1. 1 hit. [Graphical view] | ||||||||||||
| PIRSF | PIRSF000666. TyrPK_ephrin_receptor. 1 hit. | ||||||||||||
| PRINTS | PR00109. TYRKINASE. | ||||||||||||
| SMART | SM00615. EPH_lbd. 1 hit. SM00060. FN3. 2 hits. SM00454. SAM. 1 hit. SM00219. TyrKc. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF49265. FN_III-like. 2 hits. SSF49785. Gal_bind_like. 1 hit. SSF56112. Kinase_like. 1 hit. SSF47769. SAM_homology. 1 hit. | ||||||||||||
| PROSITE | PS51550. EPH_LBD. 1 hit. PS50853. FN3. 2 hits. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00109. PROTEIN_KINASE_TYR. 1 hit. PS00790. RECEPTOR_TYR_KIN_V_1. 1 hit. PS00791. RECEPTOR_TYR_KIN_V_2. 1 hit. PS50105. SAM_DOMAIN. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| BindingDB | P54753. | ||||||||||||
| ChEMBL | CHEMBL4901. | ||||||||||||
| EvolutionaryTrace | P54753. | ||||||||||||
| GenomeRNAi | 2049. | ||||||||||||
| NextBio | 8331. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | EPHB3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P54753 Secondary accession number(s): Q7Z740 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| Human chromosome 3 Human chromosome 3: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
